Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03334643 · ClinicalTrials.gov registry record · NA
Fiber Mix and Glycemic Response
A NA study of Type2 Diabetes Mellitus, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT03334643 is a NA study of Type2 Diabetes Mellitus that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 19 participants, below the 7,065-participant average among 7 other Type2 Diabetes Mellitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03334643, a NA study of Type2 Diabetes Mellitus, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
This study determines the acute effect of a dietary fiber mix on blood glucose levels. Participants will consume the fiber mix as a drink and we will monitor changes in blood glucose levels. All participants will consume white bread as the control food.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Fiber mix
Study Locations (1)
New Jersey
- Institute for Food, Nutrition & Health - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2019-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03334643
The ClinicalTrials.gov registry entry for NCT03334643 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,065-participant average among 7 other Type2 Diabetes Mellitus trials with a reported enrollment target (100% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Fiber mix is the first listed.
NCT03334643 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT03334643 about?
NCT03334643 is a clinical study titled "Fiber Mix and Glycemic Response". This study determines the acute effect of a dietary fiber mix on blood glucose levels. Participants will consume the fiber mix as a drink and we will monitor changes in blood glucose levels. All participants will consume white bread as the control food.
What is the current status of trial NCT03334643?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-06-04. Estimated completion is 2019-02-01.
What conditions does trial NCT03334643 study?
This clinical trial studies the following conditions: Type2 Diabetes Mellitus.
What interventions are being tested in trial NCT03334643?
The interventions under investigation include: Fiber mix (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03334643?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03334643 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Chronotype: Impact on Sleep and Metabolism
ACTIVE NOT RECRUITING · NA
-
Effort During Resistance Training in Type 2 Diabetes
ACTIVE NOT RECRUITING · NA
-
Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn
COMPLETED · NA
-
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
COMPLETED
-
Mil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the Latino Community
COMPLETED
-
Guide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D)
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.